TD Cowen provided research reports on Adaptive Biotechnologies on August 1, 2026.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen provided research reports on Adaptive Biotechnologies on August 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Adaptive Biotechnologies
company in Seattle, United States
Related events
- TD Cowen reissued a buy rating on NeoGenomics.
- Jefferies and TD Cowen started research coverage for Acadia Healthcare on September 3, 2026.
- Obsidian Therapeutics is headquartered in Cambridge, MA, and TD Cowen is providing investment banking coverage for the company.
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- TD Cowen upgraded Cabaletta Bio shares to strong-buy, while Jefferies reissued a buy rating, and MarketBeat provided consensus data.